4.2 Article

Establishment of iPS cell line (KLRMMEi002-A) by reprogramming peripheral blood mononuclear cells from a patient with USH2A-associated Usher syndrome

期刊

STEM CELL RESEARCH
卷 60, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.scr.2022.102699

关键词

-

资金

  1. National Natural Science Foundation of China [21318261, 3201101202, 82000943]
  2. Joint Fund of Basic and Applied Basic Research Fund of Guangdong Province [2019A1515110355]
  3. China Postdoctoral Science Foundation [2019M663391, 2021T140273]

向作者/读者索取更多资源

USH type 2 (USH2) is an autosomal recessive disorder characterized by inherited retinopathies and sensorineural hearing loss. Mutations in the USH2A gene account for a large percentage of USH2 cases. A patient-specific induced pluripotent stem (iPS) cell line with a specific USH2A gene mutation was successfully created, which can be used as a model for studying the pathogenic mechanisms of USH2A-associated disorders.
USH type 2 (USH2) is an autosomal recessive disorder that is characterized by inherited retinopathies and sensorineural hearing loss. USH type 2 (USH2) is frequently caused by USH2A mutations, which account for 74-90% of USH2 cases. We used peripheral blood mononuclear cells (PBMCs) from a USH2 patient with a USH2A gene mutation (c.8559-2A > G) to create an induced pluripotent stem (iPS) cell line. The patient-specific iPS cell line with the specific point mutation exhibited typical iPS cell characteristics, and it can be used as a model to investigate the pathogenic mechanisms underlying USH2A-associated retinal degeneration and sensorineural hearing loss.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据